285 related articles for article (PubMed ID: 26738740)
1. ELF5 isoform expression is tissue-specific and significantly altered in cancer.
Piggin CL; Roden DL; Gallego-Ortega D; Lee HJ; Oakes SR; Ormandy CJ
Breast Cancer Res; 2016 Jan; 18(1):4. PubMed ID: 26738740
[TBL] [Abstract][Full Text] [Related]
2. A novel transcription factor, ELF5, belongs to the ELF subfamily of ETS genes and maps to human chromosome 11p13-15, a region subject to LOH and rearrangement in human carcinoma cell lines.
Zhou J; Ng AY; Tymms MJ; Jermiin LS; Seth AK; Thomas RS; Kola I
Oncogene; 1998 Nov; 17(21):2719-32. PubMed ID: 9840936
[TBL] [Abstract][Full Text] [Related]
3. ELF5 suppresses estrogen sensitivity and underpins the acquisition of antiestrogen resistance in luminal breast cancer.
Kalyuga M; Gallego-Ortega D; Lee HJ; Roden DL; Cowley MJ; Caldon CE; Stone A; Allerdice SL; Valdes-Mora F; Launchbury R; Statham AL; Armstrong N; Alles MC; Young A; Egger A; Au W; Piggin CL; Evans CJ; Ledger A; Brummer T; Oakes SR; Kaplan W; Gee JM; Nicholson RI; Sutherland RL; Swarbrick A; Naylor MJ; Clark SJ; Carroll JS; Ormandy CJ
PLoS Biol; 2012; 10(12):e1001461. PubMed ID: 23300383
[TBL] [Abstract][Full Text] [Related]
4. A major site of expression of the ets transcription factor Elf5 is epithelia of exocrine glands.
Lapinskas EJ; Palmer J; Ricardo S; Hertzog PJ; Hammacher A; Pritchard MA
Histochem Cell Biol; 2004 Dec; 122(6):521-6. PubMed ID: 15655699
[TBL] [Abstract][Full Text] [Related]
5. ELF3, ELF5, EHF and SPDEF Transcription Factors in Tissue Homeostasis and Cancer.
Luk IY; Reehorst CM; Mariadason JM
Molecules; 2018 Aug; 23(9):. PubMed ID: 30200227
[TBL] [Abstract][Full Text] [Related]
6. The Ets transcription factor ELF5 functions as a tumor suppressor in the kidney.
Lapinskas EJ; Svobodova S; Davis ID; Cebon J; Hertzog PJ; Pritchard MA
Twin Res Hum Genet; 2011 Aug; 14(4):316-22. PubMed ID: 21787113
[TBL] [Abstract][Full Text] [Related]
7. Ets-1 activates parathyroid hormone-related protein gene expression in tumorigenic breast epithelial cells.
Cataisson C; Gordon J; Roussière M; Abdalkhani A; Lindemann R; Dittmer J; Foley J; Bouizar Z
Mol Cell Endocrinol; 2003 Jun; 204(1-2):155-68. PubMed ID: 12850290
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic regulation of Elf5 is associated with epithelial-mesenchymal transition in urothelial cancer.
Wu B; Cao X; Liang X; Zhang X; Zhang W; Sun G; Wang D
PLoS One; 2015; 10(1):e0117510. PubMed ID: 25629735
[TBL] [Abstract][Full Text] [Related]
9. Lineage specific methylation of the Elf5 promoter in mammary epithelial cells.
Lee HJ; Hinshelwood RA; Bouras T; Gallego-Ortega D; Valdés-Mora F; Blazek K; Visvader JE; Clark SJ; Ormandy CJ
Stem Cells; 2011 Oct; 29(10):1611-9. PubMed ID: 21823211
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the human and mouse ETV1/ER81 transcription factor genes: role of the two alternatively spliced isoforms in the human.
Coutte L; Monté D; Imai K; Pouilly L; Dewitte F; Vidaud M; Adamski J; Baert JL; de Launoit Y
Oncogene; 1999 Nov; 18(46):6278-86. PubMed ID: 10597226
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide search identifies Ccnd2 as a direct transcriptional target of Elf5 in mouse mammary gland.
Escamilla-Hernandez R; Chakrabarti R; Romano RA; Smalley K; Zhu Q; Lai W; Halfon MS; Buck MJ; Sinha S
BMC Mol Biol; 2010 Sep; 11():68. PubMed ID: 20831799
[TBL] [Abstract][Full Text] [Related]
12. Elf5 inhibits the epithelial-mesenchymal transition in mammary gland development and breast cancer metastasis by transcriptionally repressing Snail2.
Chakrabarti R; Hwang J; Andres Blanco M; Wei Y; Lukačišin M; Romano RA; Smalley K; Liu S; Yang Q; Ibrahim T; Mercatali L; Amadori D; Haffty BG; Sinha S; Kang Y
Nat Cell Biol; 2012 Nov; 14(11):1212-22. PubMed ID: 23086238
[TBL] [Abstract][Full Text] [Related]
13. Profile of Ets gene expression in human breast carcinoma.
He J; Pan Y; Hu J; Albarracin C; Wu Y; Dai JL
Cancer Biol Ther; 2007 Jan; 6(1):76-82. PubMed ID: 17172821
[TBL] [Abstract][Full Text] [Related]
14. Novel TNS3-MAP3K3 and ZFPM2-ELF5 fusion genes identified by RNA sequencing in multicystic mesothelioma with t(7;17)(p12;q23) and t(8;11)(q23;p13).
Panagopoulos I; Gorunova L; Davidson B; Heim S
Cancer Lett; 2015 Feb; 357(2):502-9. PubMed ID: 25484136
[TBL] [Abstract][Full Text] [Related]
15. ELF5 inhibits the proliferation and invasion of breast cancer cells by regulating CD24.
Qu X; Li Q; Tu S; Yang X; Wen W
Mol Biol Rep; 2021 Jun; 48(6):5023-5032. PubMed ID: 34146197
[TBL] [Abstract][Full Text] [Related]
16. ELF5 Drives Lung Metastasis in Luminal Breast Cancer through Recruitment of Gr1+ CD11b+ Myeloid-Derived Suppressor Cells.
Gallego-Ortega D; Ledger A; Roden DL; Law AM; Magenau A; Kikhtyak Z; Cho C; Allerdice SL; Lee HJ; Valdes-Mora F; Herrmann D; Salomon R; Young AI; Lee BY; Sergio CM; Kaplan W; Piggin C; Conway JR; Rabinovich B; Millar EK; Oakes SR; Chtanova T; Swarbrick A; Naylor MJ; O'Toole S; Green AR; Timpson P; Gee JM; Ellis IO; Clark SJ; Ormandy CJ
PLoS Biol; 2015 Dec; 13(12):e1002330. PubMed ID: 26717410
[TBL] [Abstract][Full Text] [Related]
17. Transcript profiling of Elf5+/- mammary glands during pregnancy identifies novel targets of Elf5.
Rogers RL; Van Seuningen I; Gould J; Hertzog PJ; Naylor MJ; Pritchard MA
PLoS One; 2010 Oct; 5(10):e13150. PubMed ID: 20949099
[TBL] [Abstract][Full Text] [Related]
18. ETS transcription factor ELF5 induces lumen formation in a 3D model of mammary morphogenesis and its expression is inhibited by Jak2 inhibitor TG101348.
Chean J; Chen CJ; Shively JE
Exp Cell Res; 2017 Oct; 359(1):62-75. PubMed ID: 28800960
[TBL] [Abstract][Full Text] [Related]
19. Determination of the consensus DNA-binding sequence and a transcriptional activation domain for ESE-2.
Choi YS; Sinha S
Biochem J; 2006 Sep; 398(3):497-507. PubMed ID: 16704374
[TBL] [Abstract][Full Text] [Related]
20. Expression of the ETS transcription factor ELF3 in the retinal pigment epithelium.
Jobling AI; Fang Z; Koleski D; Tymms MJ
Invest Ophthalmol Vis Sci; 2002 Nov; 43(11):3530-7. PubMed ID: 12407165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
